Clinical Trials Directory

Trials / Unknown

UnknownNCT04094714

CHACO Study: Control of Arterial Hypertension in Colombian Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
1,100 (estimated)
Sponsor
Scandinavia Pharma · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

Detailed description

OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment. MATERIALS AND METHODS: Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in "mono-tablet" versus "multi-tablet". The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.

Conditions

Timeline

Start date
2019-06-27
Primary completion
2023-12-01
Completion
2024-07-01
First posted
2019-09-19
Last updated
2019-09-23

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT04094714. Inclusion in this directory is not an endorsement.